Circulating Melanoma Cells in Metastatic Patients Treated With Selective BRAF Inhibitors

Clinical trial NCT01878396 · UNKNOWN

Trial details

NCT number: NCT01878396
Sponsor: Istituto Oncologico Veneto IRCCS
Status: UNKNOWN
Study type: OBSERVATIONAL

Metastatic Melanoma

Start date: 2011-12-01
Primary completion: 2016-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.